US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relmada Therapeutics, Inc.

0.8349

+0.01491.82%

Post-market: 0.7800-0.0549-6.58%19:29 EDT

Volume:477.71K

Turnover:403.07K

Market Cap:27.71M

PE:-0.33

High:0.9000

Open:0.8231

Low:0.7862

Close:0.8200

Loading ...

Overview Company News Filings

BUZZ-Relmada Therapeutics explores strategic options; shares up

Relmada Therapeutics Shares up 7% After Co Says It Will Explore Strategic Alternatives Including a Sale

THOMSON REUTERS

Relmada Therapeutics Exploring Sale After Lead Program Failure

Relmada discontinues late-stage trials for depression drug, explores sale

BRIEF-Relmada Therapeutics To Discontinue The Reliance Ii And Relight Phase 3 Studies Of Rel-1017

Relmada Therapeutics to Discontinue the Reliance Ii and Relight Phase 3 Studies of Rel-1017

THOMSON REUTERS

Relmada Therapeutics Inc: Will Continue to Advance Phase 1 Study of Rel-P11, an Investigational Agent for Treatment of Metabolic Disease

THOMSON REUTERS

Relmada Therapeutics Inc: to Explore Strategic Alternatives

THOMSON REUTERS

Press Release: Relmada Therapeutics to Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017

Relmada Shares Continue Downward Spiral After Downgrades

MT Newswires Live

Mizuho Securities downgrades Relmada Therapeutics (RLMD) to a Hold

Mizuho Downgrades Relmada Therapeutics to Neutral From Outperform, Adjusts Price Target to $1 From $23

MT Newswires Live

Relmada Therapeutics Inc : Mizuho Cuts to Neutral From Outperform

THOMSON REUTERS

U.S. RESEARCH ROUNDUP- Autozone, Costco Wholesale, Salesforce

Relmada Therapeutics Inc : Leerink Partners Cuts Target Price to $1 From $10

THOMSON REUTERS

Leerink Partners Downgrades Relmada Therapeutics to Market Perform From Outperform, $1 Price Target; Shares Plummet

MT Newswires Live

Relmada Therapeutics Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $0.60 From $13

THOMSON REUTERS

Relmada Therapeutics Shares Down 76.5% After Analysis Shows Depression Drug Unlikely to Meet Main Goal

THOMSON REUTERS

Relmada Study of Major-Depression Treatment Deemed Futile; Shares Plummet - Update

BUZZ-Relmada Therapeutics slumps as depression drug unlikely to meet main trial goal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RLMD/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RLMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLMD\",,,,,undefined,":{"symbol":"RLMD","market":"US","secType":"STK","nameCN":"Relmada Therapeutics, Inc.","latestPrice":0.8349,"timestamp":1749240000000,"preClose":0.82,"halted":0,"volume":477709,"hourTrading":{"tag":"盘后","latestPrice":0.78,"preClose":0.8349,"latestTime":"19:29 EDT","volume":3427,"amount":2695.5146,"timestamp":1749252599473},"delay":0,"floatShares":24521688,"shares":33191622,"eps":-2.504245,"marketStatus":"Market Closed","change":0.0149,"latestTime":"06-06 16:00:00 EDT","open":0.8231,"high":0.9,"low":0.7862,"amount":403067.82862620003,"amplitude":0.13878,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.504245,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.82,"preHourTrading":{"tag":"盘前","latestPrice":0.8418,"preClose":0.82,"latestTime":"09:23 EDT","volume":4895,"amount":4115.397825,"timestamp":1749216203399},"postHourTrading":{"tag":"盘后","latestPrice":0.78,"preClose":0.8349,"latestTime":"19:29 EDT","volume":3427,"amount":2695.5146,"timestamp":1749252599473},"volumeRatio":0.8666837930027224,"impliedVol":1.2563,"impliedVolPercentile":0.416},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLMD\",,,,,undefined,":{"symbol":"RLMD","floatShares":24521688,"roa":"-88.24%","roe":"-160.26%","lyrEps":-2.651505,"volumeRatio":0.8666837930027224,"shares":33191622,"dividePrice":0,"high":0.9,"amplitude":0.13878,"preClose":0.82,"low":0.7862,"week52Low":0.2404,"pbRate":"1.23","week52High":4.47,"institutionHeld":0,"latestPrice":0.8349,"eps":-2.504245,"divideRate":0,"volume":477709,"delay":0,"ttmEps":-2.504245,"open":0.8231,"prevYearClose":0.52,"prevWeekClose":0.75,"prevMonthClose":0.75,"prevQuarterClose":0.27,"fiveDayClose":0.75,"twentyDayClose":0.3633,"sixtyDayClose":0.27},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RLMD\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490677442","title":"BUZZ-Relmada Therapeutics explores strategic options; shares up","url":"https://stock-news.laohu8.com/highlight/detail?id=2490677442","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490677442?lang=en_us&edition=fundamental","pubTime":"2024-12-09 23:58","pubTimestamp":1733759912,"startTime":"0","endTime":"0","summary":"** Shares of drug developer Relmada Therapeutics    rise 4.9% to 48 cents     ** Co says it has commenced a process to explore strategic alternatives after discontinuing two late-stage studies planned for the development of its depression drug   ** Co plans to consider a wide range of options including sale of company assets, a sale of the company, a merger or a reverse merger; adds it has not set a timetable for completion of the evaluation process   ** Says co is in the process of engaging a financial advisor to assist in the strategic review process   ** The stock fell more than 70% last week after the company said its depression drug, esmethadone, was \"unlikely\" to meet the main goal of a late-stage trial    ** Including session moves, stock down 88.4% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","RLMD","BK4139","BK4007"],"gpt_icon":0},{"id":"2490334773","title":"Relmada Therapeutics Shares up 7% After Co Says It Will Explore Strategic Alternatives Including a Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2490334773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490334773?lang=en_us&edition=fundamental","pubTime":"2024-12-09 22:34","pubTimestamp":1733754857,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2490772453","title":"Relmada Therapeutics Exploring Sale After Lead Program Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2490772453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490772453?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:59","pubTimestamp":1733749140,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics has put itself up for sale following the failure of the biotechnology company's lead asset in a late-stage study.Relmada on Monday said it is ending Phase 3 studies of its REL-1017 program and exploring ways to maximize shareholder value on the heels of last week's news that one of the studies was unlikely to meet its primary endpoint in major depressive disorder.Relmada said it is working to hire a financial adviser to assist in a strategic review process that will include a range of options, including a potential sale of the Coral Gables, Fla., company or its assets.The company said it will also continue to advance a Phase 1 study of its REL-P11 investigational agent for the treatment of metabolic disease.Relmada shares collapsed last week after the company disclosed the study failure, ending Friday's session at 45.8 cents, down about 85% for the week.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2490729001","title":"Relmada discontinues late-stage trials for depression drug, explores sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729001","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729001?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:39","pubTimestamp":1733747979,"startTime":"0","endTime":"0","summary":"Dec 9  - Relmada Therapeutics    said on Monday it would discontinue the two late-stage studies planned for the development of its depression drug and explore strategic alternatives including a sale.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2490294627","title":"BRIEF-Relmada Therapeutics To Discontinue The Reliance Ii And Relight Phase 3 Studies Of Rel-1017","url":"https://stock-news.laohu8.com/highlight/detail?id=2490294627","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490294627?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:35","pubTimestamp":1733747754,"startTime":"0","endTime":"0","summary":"BRIEF-Relmada Therapeutics To Discontinue The Reliance Ii And Relight Phase 3 Studies Of Rel-1017Dec 9 (Reuters) - Relmada Therapeutics RLMD.O:RELMADA THERAPEUTICS TO DISCONTINUE THE RELIANCE II AND R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2490729658","title":"Relmada Therapeutics to Discontinue the Reliance Ii and Relight Phase 3 Studies of Rel-1017","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729658?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:30","pubTimestamp":1733747404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2490729648","title":"Relmada Therapeutics Inc: Will Continue to Advance Phase 1 Study of Rel-P11, an Investigational Agent for Treatment of Metabolic Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729648?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:30","pubTimestamp":1733747404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1BH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2490729645","title":"Relmada Therapeutics Inc: to Explore Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729645","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729645?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:30","pubTimestamp":1733747404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1BH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2490729546","title":"Press Release: Relmada Therapeutics to Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729546","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729546?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:30","pubTimestamp":1733747400,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics has Commenced a Process to Explore Strategic Alternatives to Maximize Shareholder Value. CORAL GABLES, Fla., Dec. 09, 2024  -- Relmada Therapeutics, Inc. , a late-stage biotechnology company addressing diseases of the central nervous system , today announced that in light of the recent data monitoring committee  evaluation of the full dataset from the Reliance II Phase 3 study of the Company's REL-1017 program, the Company will discontinue the Reliance II and Relight Phase 3 studies. The Company will continue to advance the Phase 1 study of REL-P11, an investigational agent for the treatment of metabolic disease, currently in a Phase 1 first-in-human study.The Company has not set a timetable for completion of the evaluation process and does not intend to disclose further developments or guidance on the status of its exploration of strategic alternatives unless and until it is determined that further disclosure is appropriate or necessary.Relmada Therapeutics is a l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","03160","LENZ","BK4588","BK4007","CNS","BK4139","TM","BK4099","BK4555","BK4585","BK4135"],"gpt_icon":0},{"id":"2489965454","title":"Relmada Shares Continue Downward Spiral After Downgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=2489965454","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489965454?lang=en_us&edition=fundamental","pubTime":"2024-12-06 02:31","pubTimestamp":1733423517,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics  shares continued falling on Thursday after some analysts downgraded its stock following failure in late-stage trial of anti-depressant candidate.Mizuho downgraded the stock to neutral from outperform and slashed its price target to $1 from $23, while Leerink Partners lowered its rating to market perform from outperform, also with a $1 price target.Relmada on Wednesday said that an independent data monitoring committee has determined that a late-stage study of REL-1017 as an adjunctive treatment for major depressive disorder is \"futile.\" The company will determine its next steps after assessing the full dataset.The company's stock was down nearly 16% in recent trading after falling more than 70% on Wednesday.Price: 0.53, Change: -0.10, Percent Change: -15.71","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RLMD"],"gpt_icon":0},{"id":"2489493420","title":"Mizuho Securities downgrades Relmada Therapeutics (RLMD) to a Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2489493420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489493420?lang=en_us&edition=fundamental","pubTime":"2024-12-06 01:55","pubTimestamp":1733421334,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics (RLMD – Research Report) received a Hold rating and a $1.00 price target from Mizuho Securities analyst Uy Ear yesterday. The ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-downgrades-relmada-therapeutics-rlmd-to-a-hold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-downgrades-relmada-therapeutics-rlmd-to-a-hold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RLMD","MFG"],"gpt_icon":0},{"id":"2489062459","title":"Mizuho Downgrades Relmada Therapeutics to Neutral From Outperform, Adjusts Price Target to $1 From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2489062459","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489062459?lang=en_us&edition=fundamental","pubTime":"2024-12-05 21:38","pubTimestamp":1733405896,"startTime":"0","endTime":"0","summary":"Mizuho Downgrades Relmada Therapeutics to Neutral From Outperform, Adjusts Price Target to $1 From $23","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RLMD","MFG","LENZ"],"gpt_icon":0},{"id":"2489486158","title":"Relmada Therapeutics Inc : Mizuho Cuts to Neutral From Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2489486158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489486158?lang=en_us&edition=fundamental","pubTime":"2024-12-05 15:46","pubTimestamp":1733384794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241205:nFWN3N602Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2489485894","title":"U.S. RESEARCH ROUNDUP- Autozone, Costco Wholesale, Salesforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2489485894","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489485894?lang=en_us&edition=fundamental","pubTime":"2024-12-05 15:19","pubTimestamp":1733383175,"startTime":"0","endTime":"0","summary":"Dec 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autozone, Costco Wholesale and Salesforce on Thursday.  HIGHLIGHTS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EW","CDMO","RLMD","GXO","AZO","ASB","CHWY","NCNO","CPB","CXM","DLTR","PRO","CHPT","FL","CRM","KMX","CCRN","COST"],"gpt_icon":1},{"id":"2489071331","title":"Relmada Therapeutics Inc : Leerink Partners Cuts Target Price to $1 From $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2489071331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489071331?lang=en_us&edition=fundamental","pubTime":"2024-12-05 14:06","pubTimestamp":1733378809,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241205:nFWN3N51WI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2489103911","title":"Leerink Partners Downgrades Relmada Therapeutics to Market Perform From Outperform, $1 Price Target; Shares Plummet","url":"https://stock-news.laohu8.com/highlight/detail?id=2489103911","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489103911?lang=en_us&edition=fundamental","pubTime":"2024-12-05 01:54","pubTimestamp":1733334858,"startTime":"0","endTime":"0","summary":"Price: 0.66, Change: -2.11, Percent Change: -76.25","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","RLMD"],"gpt_icon":0},{"id":"2488118209","title":"Relmada Therapeutics Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $0.60 From $13","url":"https://stock-news.laohu8.com/highlight/detail?id=2488118209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488118209?lang=en_us&edition=fundamental","pubTime":"2024-12-04 23:05","pubTimestamp":1733324718,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nFWN3N51GO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2488719472","title":"Relmada Therapeutics Shares Down 76.5% After Analysis Shows Depression Drug Unlikely to Meet Main Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2488719472","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488719472?lang=en_us&edition=fundamental","pubTime":"2024-12-04 22:32","pubTimestamp":1733322738,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nFWN3N51S5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2488196479","title":"Relmada Study of Major-Depression Treatment Deemed Futile; Shares Plummet - Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2488196479","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488196479?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:40","pubTimestamp":1733319600,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics lost more than two-thirds of its market value early Wednesday after the biotechnology company said a treatment for major depressive disorder would likely fail to meet its primary goal in a trial it deemed futile.Shares of Relmada dropped 77% to 64 cents in premarket trading. The stock already was down by about a third since the start of the year, as of Tuesday's close.The Coral Gables, Fla., company said an interim analysis by an independent data monitoring committee found the treatment was unlikely to meet the primary endpoint with statistical significance in a Phase 3 study.The treatment, REL-1017, was being evaluated as an adjunctive treatment for major depressive disorder to be used in combination with other approved anti-depressants.Relmada said no new safety signals were reported.\"Based on these results, Relmada will evaluate the full dataset to determine next steps for the REL-1017 program,\" Chief Executive Sergio Traversa said.Relmada said it will focus on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Relmada Study of Major-Depression Treatment Deemed Futile; Shares Plummet - Update","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2488219516","title":"BUZZ-Relmada Therapeutics slumps as depression drug unlikely to meet main trial goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2488219516","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488219516?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:28","pubTimestamp":1733318881,"startTime":"0","endTime":"0","summary":"** Shares of drug developer Relmada Therapeutics    fall 77.6% to 62 cents premarket   ** Co says its depression treatment is \"unlikely\" to meet the main goal of a late-stage trial, according to an independent data monitoring committee's analysis   ** Co was testing the treatment, REL-1017, as an additional treatment for major depressive disorder to be used in combination with other approved anti-depressants   ** Based on these results, Relmada will evaluate the full dataset to determine next steps for the REL-1017 program - RLMD   ** Co had about $54.1 million in cash and cash equivalents as of September 30, 2024   ** Up to last close, stock down 33% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007","BK4139","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":70,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RLMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"RLMD","fiscalQuarterEnding":"2025/03","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2025-03-27","symbol":"RLMD","fiscalQuarterEnding":"2024/12","expectedEps":-0.7,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2024-11-07","symbol":"RLMD","fiscalQuarterEnding":"2024/09","expectedEps":-0.65,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.72},{"market":"US","date":"2024-08-07","symbol":"RLMD","fiscalQuarterEnding":"2024/06","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.59},{"market":"US","date":"2024-05-08","symbol":"RLMD","fiscalQuarterEnding":"2024/03","expectedEps":-0.9,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RLMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RLMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1733371200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RLMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RLMD","date":"2025-06-06","current":-0.359489,"percent":0.899356,"low":-33.036996,"twenty":-7.947417,"median":-1.470281,"eighty":-0.659728,"high":-0.088966,"avg":-5.238401,"sd":6.818833,"marketCap":27217130},"quantilePoints":[{"date":"2020-06-12","current":-31.047373,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":713855179},{"date":"2020-06-19","current":-31.569567,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":725861685},{"date":"2020-06-26","current":-28.667758,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":659141987},{"date":"2020-07-02","current":-28.277765,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":650175103},{"date":"2020-07-10","current":-27.980313,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":643335953},{"date":"2020-07-17","current":-27.980313,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":643335953},{"date":"2020-07-24","current":-25.785779,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":592878232},{"date":"2020-07-31","current":-24.040727,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":552755224},{"date":"2020-08-07","current":-23.743276,"twenty":-5.700374,"median":-1.733041,"eighty":-0.357515,"marketCap":545916075},{"date":"2020-08-14","current":-19.888133,"twenty":-5.712286,"median":-1.733041,"eighty":-0.357515,"marketCap":596411270},{"date":"2020-08-21","current":-20.876662,"twenty":-5.737576,"median":-1.733041,"eighty":-0.357515,"marketCap":626055570},{"date":"2020-08-28","current":-18.637777,"twenty":-5.855718,"median":-1.733041,"eighty":-0.357515,"marketCap":558915236},{"date":"2020-09-04","current":-19.610276,"twenty":-5.948456,"median":-1.733041,"eighty":-0.357515,"marketCap":588078818},{"date":"2020-09-11","current":-19.36448,"twenty":-6.126741,"median":-1.733041,"eighty":-0.357515,"marketCap":580707803},{"date":"2020-09-18","current":-21.469779,"twenty":-6.279615,"median":-1.733041,"eighty":-0.357515,"marketCap":643842150},{"date":"2020-09-25","current":-19.66371,"twenty":-6.401962,"median":-1.733041,"eighty":-0.357515,"marketCap":589681212},{"date":"2020-10-02","current":-20.956813,"twenty":-6.49254,"median":-1.758166,"eighty":-0.357515,"marketCap":628459162},{"date":"2020-10-09","current":-20.860631,"twenty":-6.752577,"median":-1.818793,"eighty":-0.357515,"marketCap":625574851},{"date":"2020-10-16","current":-18.62709,"twenty":-13.145747,"median":-1.818793,"eighty":-0.357515,"marketCap":558594757},{"date":"2020-10-23","current":-17.814894,"twenty":-14.590145,"median":-1.853436,"eighty":-0.357515,"marketCap":534238359},{"date":"2020-10-30","current":-16.527134,"twenty":-14.890092,"median":-1.884167,"eighty":-0.357515,"marketCap":495620649},{"date":"2020-11-06","current":-17.040101,"twenty":-15.202709,"median":-1.905402,"eighty":-0.357515,"marketCap":511003637},{"date":"2020-11-13","current":-12.23902,"twenty":-15.348585,"median":-1.975556,"eighty":-0.357515,"marketCap":528986501},{"date":"2020-11-20","current":-13.854856,"twenty":-15.348585,"median":-2.000672,"eighty":-0.357515,"marketCap":598825063},{"date":"2020-11-27","current":-13.524173,"twenty":-15.348585,"median":-2.052637,"eighty":-0.357515,"marketCap":584532520},{"date":"2020-12-04","current":-13.152155,"twenty":-15.348585,"median":-2.07862,"eighty":-0.357515,"marketCap":568453410},{"date":"2020-12-11","current":-12.344237,"twenty":-15.348585,"median":-2.07862,"eighty":-0.357515,"marketCap":533534129},{"date":"2020-12-18","current":-12.663647,"twenty":-15.348585,"median":-2.160184,"eighty":-0.357515,"marketCap":547339426},{"date":"2020-12-24","current":-12.069921,"twenty":-15.348585,"median":-2.191878,"eighty":-0.357515,"marketCap":521677815},{"date":"2020-12-31","current":-12.051132,"twenty":-15.348585,"median":-2.251839,"eighty":-0.357515,"marketCap":520865738},{"date":"2021-01-08","current":-13.309981,"twenty":-15.348585,"median":-2.315052,"eighty":-0.357515,"marketCap":575274850},{"date":"2021-01-15","current":-13.854856,"twenty":-15.348585,"median":-2.359402,"eighty":-0.357515,"marketCap":598825063},{"date":"2021-01-22","current":-13.426472,"twenty":-15.348585,"median":-2.390413,"eighty":-0.361852,"marketCap":580309723},{"date":"2021-01-29","current":-12.280355,"twenty":-15.348585,"median":-2.511008,"eighty":-0.36481,"marketCap":530773069},{"date":"2021-02-05","current":-12.716255,"twenty":-15.348585,"median":-2.576427,"eighty":-0.370059,"marketCap":549613239},{"date":"2021-02-12","current":-13.704546,"twenty":-15.348585,"median":-2.617786,"eighty":-0.372159,"marketCap":592328453},{"date":"2021-02-19","current":-14.035229,"twenty":-15.348585,"median":-2.645672,"eighty":-0.372159,"marketCap":606620996},{"date":"2021-02-26","current":-12.528367,"twenty":-15.348585,"median":-2.728189,"eighty":-0.372159,"marketCap":541492476},{"date":"2021-03-05","current":-12.862808,"twenty":-15.354462,"median":-2.841532,"eighty":-0.371634,"marketCap":555947434},{"date":"2021-03-12","current":-13.779701,"twenty":-15.354462,"median":-2.841532,"eighty":-0.391734,"marketCap":595576758},{"date":"2021-03-19","current":-13.742123,"twenty":-15.354462,"median":-2.877762,"eighty":-0.424703,"marketCap":593952605},{"date":"2021-03-26","current":-9.271938,"twenty":-15.348585,"median":-2.890274,"eighty":-0.43007,"marketCap":551276015},{"date":"2021-04-01","current":-10.323333,"twenty":-15.348585,"median":-2.926862,"eighty":-0.438333,"marketCap":613788141},{"date":"2021-04-09","current":-9.923356,"twenty":-15.354462,"median":-2.987177,"eighty":-0.437014,"marketCap":590006991},{"date":"2021-04-16","current":-9.771253,"twenty":-15.354462,"median":-3.013299,"eighty":-0.437014,"marketCap":580963455},{"date":"2021-04-23","current":-10.376851,"twenty":-15.354462,"median":-3.039204,"eighty":-0.437014,"marketCap":616970126},{"date":"2021-04-30","current":-10.861329,"twenty":-15.354462,"median":-3.077954,"eighty":-0.437014,"marketCap":645775463},{"date":"2021-05-07","current":-10.236014,"twenty":-15.354462,"median":-3.096464,"eighty":-0.437014,"marketCap":608596482},{"date":"2021-05-14","current":-8.003248,"twenty":-15.354462,"median":-3.13772,"eighty":-0.437014,"marketCap":568216697},{"date":"2021-05-21","current":-8.968464,"twenty":-15.354462,"median":-3.169112,"eighty":-0.437014,"marketCap":636745344},{"date":"2021-05-28","current":-8.183043,"twenty":-15.354462,"median":-3.187536,"eighty":-0.437014,"marketCap":580981837},{"date":"2021-06-04","current":-7.12793,"twenty":-15.354462,"median":-3.192703,"eighty":-0.437014,"marketCap":506070620},{"date":"2021-06-11","current":-7.366868,"twenty":-15.354462,"median":-3.196717,"eighty":-0.437014,"marketCap":523034820},{"date":"2021-06-18","current":-7.310091,"twenty":-15.354462,"median":-3.215186,"eighty":-0.437014,"marketCap":519003723},{"date":"2021-06-25","current":-8.126266,"twenty":-15.354462,"median":-3.245915,"eighty":-0.437014,"marketCap":576950740},{"date":"2021-07-02","current":-7.71463,"twenty":-15.354462,"median":-3.278609,"eighty":-0.437014,"marketCap":547725288},{"date":"2021-07-09","current":-8.097877,"twenty":-15.354462,"median":-3.296823,"eighty":-0.437014,"marketCap":574935192},{"date":"2021-07-16","current":-7.373965,"twenty":-15.354462,"median":-3.315038,"eighty":-0.443169,"marketCap":523538707},{"date":"2021-07-23","current":-6.127228,"twenty":-15.354462,"median":-3.370574,"eighty":-0.443169,"marketCap":435022538},{"date":"2021-07-30","current":-6.150886,"twenty":-15.354462,"median":-3.371104,"eighty":-0.555367,"marketCap":436702162},{"date":"2021-08-06","current":-5.568917,"twenty":-15.354462,"median":-3.380611,"eighty":-0.578507,"marketCap":395383418},{"date":"2021-08-13","current":-4.61934,"twenty":-15.354462,"median":-3.397035,"eighty":-0.605119,"marketCap":399257730},{"date":"2021-08-20","current":-4.534433,"twenty":-15.354462,"median":-3.424324,"eighty":-0.659499,"marketCap":391919075},{"date":"2021-08-27","current":-4.890234,"twenty":-15.354462,"median":-3.448899,"eighty":-0.746275,"marketCap":422671531},{"date":"2021-09-03","current":-4.932687,"twenty":-15.354462,"median":-3.460753,"eighty":-0.821481,"marketCap":426340858},{"date":"2021-09-10","current":-5.260185,"twenty":-15.354462,"median":-3.485622,"eighty":-0.850406,"marketCap":454647095},{"date":"2021-09-17","current":-5.571511,"twenty":-15.354462,"median":-3.500762,"eighty":-0.850406,"marketCap":481555494},{"date":"2021-09-24","current":-5.882836,"twenty":-15.354462,"median":-3.51567,"eighty":-0.850406,"marketCap":508463892},{"date":"2021-10-01","current":-5.40574,"twenty":-15.354462,"median":-3.578556,"eighty":-0.970791,"marketCap":467227645},{"date":"2021-10-08","current":-5.290509,"twenty":-15.354462,"median":-3.584692,"eighty":-1.000536,"marketCap":457268043},{"date":"2021-10-15","current":-4.777025,"twenty":-15.354462,"median":-3.605816,"eighty":-1.014057,"marketCap":412886659},{"date":"2021-10-22","current":-4.815435,"twenty":-15.354462,"median":-3.628468,"eighty":-1.022224,"marketCap":416206526},{"date":"2021-10-29","current":-4.744679,"twenty":-15.354462,"median":-3.668784,"eighty":-1.054619,"marketCap":410090981},{"date":"2021-11-05","current":-5.314768,"twenty":-15.354462,"median":-3.690124,"eighty":-1.081661,"marketCap":459364801},{"date":"2021-11-12","current":-3.567592,"twenty":-15.354462,"median":-3.789733,"eighty":-1.415629,"marketCap":400053540},{"date":"2021-11-19","current":-3.187695,"twenty":-15.354462,"median":-3.789733,"eighty":-1.448079,"marketCap":357453623},{"date":"2021-11-26","current":-2.943811,"twenty":-15.354462,"median":-3.789733,"eighty":-1.458021,"marketCap":330105528},{"date":"2021-12-03","current":-2.646772,"twenty":-15.354462,"median":-3.789733,"eighty":-1.458229,"marketCap":296796951},{"date":"2021-12-10","current":-4.42415,"twenty":-15.354462,"median":-3.795557,"eighty":-1.477343,"marketCap":496104008},{"date":"2021-12-17","current":-4.705268,"twenty":-15.354462,"median":-3.795557,"eighty":-1.499231,"marketCap":527627378},{"date":"2021-12-23","current":-5.501431,"twenty":-15.354462,"median":-3.909674,"eighty":-1.532958,"marketCap":616905369},{"date":"2021-12-31","current":-5.570662,"twenty":-15.354462,"median":-4.004888,"eighty":-1.552453,"marketCap":624668672},{"date":"2022-01-07","current":-5.170108,"twenty":-15.348585,"median":-4.217285,"eighty":-1.558965,"marketCap":579752416},{"date":"2022-01-14","current":-4.91049,"twenty":-15.348585,"median":-4.421677,"eighty":-1.560442,"marketCap":550640028},{"date":"2022-01-21","current":-4.591531,"twenty":-15.348585,"median":-4.551617,"eighty":-1.56326,"marketCap":514873379},{"date":"2022-01-28","current":-4.32944,"twenty":-15.348585,"median":-4.580166,"eighty":-1.579649,"marketCap":485483730},{"date":"2022-02-04","current":-4.195923,"twenty":-15.348585,"median":-4.580166,"eighty":-1.584662,"marketCap":470511645},{"date":"2022-02-11","current":-4.569278,"twenty":-15.348585,"median":-4.605436,"eighty":-1.606919,"marketCap":512378032},{"date":"2022-02-18","current":-4.517354,"twenty":-15.348585,"median":-4.634752,"eighty":-1.627238,"marketCap":506555554},{"date":"2022-02-25","current":-5.081097,"twenty":-15.348585,"median":-4.649032,"eighty":-1.637901,"marketCap":569771026},{"date":"2022-03-04","current":-5.093459,"twenty":-15.348585,"median":-4.686724,"eighty":-1.645574,"marketCap":571157330},{"date":"2022-03-11","current":-5.498958,"twenty":-15.348585,"median":-4.748722,"eighty":-1.671902,"marketCap":616628108},{"date":"2022-03-18","current":-5.953908,"twenty":-15.348585,"median":-4.779046,"eighty":-1.671902,"marketCap":667644102},{"date":"2022-03-25","current":-6.013944,"twenty":-15.348585,"median":-4.795535,"eighty":-1.724543,"marketCap":756264367},{"date":"2022-04-01","current":-6.866406,"twenty":-15.348585,"median":-4.819018,"eighty":-1.749505,"marketCap":863463006},{"date":"2022-04-08","current":-6.209434,"twenty":-15.348585,"median":-4.84677,"eighty":-1.815329,"marketCap":780847514},{"date":"2022-04-14","current":-6.092407,"twenty":-15.348585,"median":-4.910514,"eighty":-1.818793,"marketCap":766131202},{"date":"2022-04-22","current":-5.727284,"twenty":-15.348585,"median":-4.93957,"eighty":-1.836115,"marketCap":720216309},{"date":"2022-04-29","current":-5.877078,"twenty":-15.348585,"median":-4.99703,"eighty":-1.869901,"marketCap":739053188},{"date":"2022-05-06","current":-4.443703,"twenty":-15.348585,"median":-5.010782,"eighty":-1.905402,"marketCap":636704471},{"date":"2022-05-13","current":-4.144386,"twenty":-15.348585,"median":-5.010782,"eighty":-1.940046,"marketCap":593817642},{"date":"2022-05-20","current":-4.20718,"twenty":-15.348585,"median":-5.010782,"eighty":-1.992011,"marketCap":602814879},{"date":"2022-05-27","current":-4.148572,"twenty":-15.348585,"median":-5.010782,"eighty":-2.040855,"marketCap":594417457},{"date":"2022-06-03","current":-4.058568,"twenty":-15.348585,"median":-5.010782,"eighty":-2.078009,"marketCap":581521418},{"date":"2022-06-10","current":-3.767624,"twenty":-15.348585,"median":-5.010782,"eighty":-2.07862,"marketCap":539834220},{"date":"2022-06-17","current":-3.830418,"twenty":-15.348585,"median":-5.010782,"eighty":-2.107186,"marketCap":548831457},{"date":"2022-06-24","current":-4.112989,"twenty":-15.354462,"median":-5.011529,"eighty":-2.165229,"marketCap":589319023},{"date":"2022-07-01","current":-3.830418,"twenty":-15.354462,"median":-5.011529,"eighty":-2.251839,"marketCap":548831457},{"date":"2022-07-08","current":-3.958098,"twenty":-15.354462,"median":-5.011529,"eighty":-2.306182,"marketCap":567125838},{"date":"2022-07-15","current":-4.70325,"twenty":-15.354462,"median":-5.011529,"eighty":-2.355854,"marketCap":673893051},{"date":"2022-07-22","current":-4.962798,"twenty":-15.354462,"median":-5.02511,"eighty":-2.393877,"marketCap":711081630},{"date":"2022-07-29","current":-5.358398,"twenty":-15.354462,"median":-5.051511,"eighty":-2.514569,"marketCap":767764224},{"date":"2022-08-05","current":-5.479799,"twenty":-15.354462,"median":-5.071206,"eighty":-2.577332,"marketCap":785158882},{"date":"2022-08-12","current":-5.583625,"twenty":-15.354462,"median":-5.085412,"eighty":-2.618223,"marketCap":874761073},{"date":"2022-08-19","current":-5.566356,"twenty":-15.354462,"median":-5.130803,"eighty":-2.648853,"marketCap":872055627},{"date":"2022-08-26","current":-5.658457,"twenty":-15.354462,"median":-5.14291,"eighty":-2.717642,"marketCap":886484675},{"date":"2022-09-02","current":-5.702589,"twenty":-15.354462,"median":-5.161645,"eighty":-2.789962,"marketCap":893398594},{"date":"2022-09-09","current":-6.118962,"twenty":-15.354462,"median":-5.168988,"eighty":-2.83992,"marketCap":958629919},{"date":"2022-09-16","current":-6.537255,"twenty":-15.354462,"median":-5.170108,"eighty":-2.841532,"marketCap":1024161848},{"date":"2022-09-23","current":-6.120881,"twenty":-15.354462,"median":-5.21571,"eighty":-2.8635,"marketCap":958930524},{"date":"2022-09-30","current":-7.103292,"twenty":-15.354462,"median":-5.232811,"eighty":-2.877762,"marketCap":1112840376},{"date":"2022-10-07","current":-6.569874,"twenty":-15.354462,"median":-5.260185,"eighty":-2.877762,"marketCap":1029272136},{"date":"2022-10-14","current":-1.189638,"twenty":-15.354462,"median":-5.278901,"eighty":-2.870556,"marketCap":186375211},{"date":"2022-10-21","current":-1.345059,"twenty":-15.354462,"median":-5.278901,"eighty":-2.841532,"marketCap":210724231},{"date":"2022-10-28","current":-1.256795,"twenty":-15.354462,"median":-5.278901,"eighty":-2.841532,"marketCap":196896392},{"date":"2022-11-04","current":-1.220339,"twenty":-15.354462,"median":-5.278901,"eighty":-2.789962,"marketCap":191184894},{"date":"2022-11-11","current":-1.245325,"twenty":-15.354462,"median":-5.278901,"eighty":-2.717642,"marketCap":191129939},{"date":"2022-11-18","current":-1.164918,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":178789265},{"date":"2022-11-25","current":-1.029599,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":158020815},{"date":"2022-12-02","current":-0.902125,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":138456333},{"date":"2022-12-09","current":-0.525586,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":80665864},{"date":"2022-12-16","current":-0.660905,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":101434314},{"date":"2022-12-23","current":-0.590304,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":90598601},{"date":"2022-12-30","current":-0.684438,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":105046218},{"date":"2023-01-06","current":-0.645216,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":99026377},{"date":"2023-01-13","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-01-20","current":-0.933504,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":143272206},{"date":"2023-01-27","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-02-03","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-02-10","current":-0.733467,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":112571019},{"date":"2023-02-17","current":-0.719739,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":110464075},{"date":"2023-02-24","current":-0.651099,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":99929353},{"date":"2023-03-03","current":-0.698166,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":107153162},{"date":"2023-03-10","current":-0.56677,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":86986696},{"date":"2023-03-17","current":-0.484402,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":74345031},{"date":"2023-03-24","current":-0.435071,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":68325190},{"date":"2023-03-31","current":-0.433154,"twenty":-15.348585,"median":-5.270935,"eighty":-2.684884,"marketCap":68024198},{"date":"2023-04-06","current":-0.425488,"twenty":-15.348585,"median":-5.270935,"eighty":-2.684884,"marketCap":66820230},{"date":"2023-04-14","current":-0.490653,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":77053959},{"date":"2023-04-21","current":-0.511735,"twenty":-15.354462,"median":-5.278901,"eighty":-2.644504,"marketCap":80364872},{"date":"2023-04-28","current":-0.525152,"twenty":-15.354462,"median":-5.278901,"eighty":-2.598617,"marketCap":82471816},{"date":"2023-05-05","current":-0.58265,"twenty":-15.354462,"median":-5.278901,"eighty":-2.528919,"marketCap":91501577},{"date":"2023-05-12","current":-0.664355,"twenty":-15.354462,"median":-5.278901,"eighty":-2.410667,"marketCap":95414473},{"date":"2023-05-19","current":-0.651781,"twenty":-15.354462,"median":-5.278901,"eighty":-2.359402,"marketCap":93608521},{"date":"2023-05-26","current":-0.595195,"twenty":-15.354462,"median":-5.278901,"eighty":-2.316826,"marketCap":85481736},{"date":"2023-06-02","current":-0.570046,"twenty":-15.354462,"median":-5.278901,"eighty":-2.284445,"marketCap":81869832},{"date":"2023-06-09","current":-0.588908,"twenty":-15.354462,"median":-5.278901,"eighty":-2.165229,"marketCap":84578760},{"date":"2023-06-16","current":-0.534418,"twenty":-15.354462,"median":-5.278901,"eighty":-2.143555,"marketCap":76752967},{"date":"2023-06-23","current":-0.536514,"twenty":-15.360338,"median":-5.282659,"eighty":-2.165229,"marketCap":77053959},{"date":"2023-06-30","current":-0.521844,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":74947015},{"date":"2023-07-07","current":-0.52394,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":75248007},{"date":"2023-07-14","current":-0.591004,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":84879752},{"date":"2023-07-21","current":-0.62244,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":89394632},{"date":"2023-07-28","current":-0.519748,"twenty":-15.366215,"median":-5.286416,"eighty":-2.085105,"marketCap":74646023},{"date":"2023-08-04","current":-0.546993,"twenty":-15.366215,"median":-5.286416,"eighty":-2.022579,"marketCap":78558919},{"date":"2023-08-11","current":-0.66738,"twenty":-15.366215,"median":-5.286416,"eighty":-1.995475,"marketCap":86083720},{"date":"2023-08-18","current":-0.665046,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":85782728},{"date":"2023-08-25","current":-0.744385,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":96016457},{"date":"2023-09-01","current":-0.788722,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":101735306},{"date":"2023-09-08","current":-0.828391,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":106852170},{"date":"2023-09-15","current":-0.772387,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":99628361},{"date":"2023-09-22","current":-0.669713,"twenty":-15.366215,"median":-5.286416,"eighty":-1.912331,"marketCap":86384712},{"date":"2023-09-29","current":-0.686048,"twenty":-15.445182,"median":-5.286416,"eighty":-1.627406,"marketCap":88491656},{"date":"2023-10-06","current":-0.700049,"twenty":-15.518272,"median":-5.28644,"eighty":-1.900782,"marketCap":90297609},{"date":"2023-10-13","current":-0.746719,"twenty":-15.518272,"median":-5.28644,"eighty":-1.878374,"marketCap":96317449},{"date":"2023-10-20","current":-0.723384,"twenty":-15.518272,"median":-5.28644,"eighty":-1.444835,"marketCap":93307529},{"date":"2023-10-27","current":-0.732718,"twenty":-15.783249,"median":-5.288487,"eighty":-1.358874,"marketCap":94511497},{"date":"2023-11-03","current":-0.711716,"twenty":-15.783249,"median":-5.288487,"eighty":-1.26447,"marketCap":91802569},{"date":"2023-11-10","current":-0.806631,"twenty":-15.783249,"median":-5.288487,"eighty":-1.225327,"marketCap":89996616},{"date":"2023-11-17","current":-0.79584,"twenty":-15.783249,"median":-5.288487,"eighty":-1.187047,"marketCap":88792648},{"date":"2023-11-24","current":-0.782351,"twenty":-15.783249,"median":-5.288487,"eighty":-1.150072,"marketCap":87287688},{"date":"2023-11-30","current":-0.677139,"twenty":-15.828956,"median":-5.290509,"eighty":-1.129618,"marketCap":75548999},{"date":"2023-12-08","current":-0.690627,"twenty":-15.874664,"median":-5.294552,"eighty":-1.029599,"marketCap":77053959},{"date":"2023-12-15","current":-0.674441,"twenty":-15.920371,"median":-5.298596,"eighty":-0.904086,"marketCap":75248007},{"date":"2023-12-22","current":-0.79584,"twenty":-15.920371,"median":-5.298596,"eighty":-0.874579,"marketCap":88792648},{"date":"2023-12-29","current":-1.022452,"twenty":-15.966078,"median":-5.300095,"eighty":-0.866825,"marketCap":114075979},{"date":"2024-01-05","current":-0.834958,"twenty":-16.008223,"median":-5.301594,"eighty":-0.865648,"marketCap":93157033},{"date":"2024-01-12","current":-0.89296,"twenty":-16.008223,"median":-5.301594,"eighty":-0.865648,"marketCap":99628361},{"date":"2024-01-19","current":-0.919937,"twenty":-16.050367,"median":-5.303846,"eighty":-0.860157,"marketCap":102638282},{"date":"2024-01-26","current":-0.97659,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":108959114},{"date":"2024-02-02","current":-1.23018,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":137252365},{"date":"2024-02-09","current":-1.413628,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":157719823},{"date":"2024-02-16","current":-1.421721,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":158622799},{"date":"2024-02-23","current":-1.494561,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":166749584},{"date":"2024-03-01","current":-1.65238,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":184357618},{"date":"2024-03-08","current":-1.718475,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":191731923},{"date":"2024-03-15","current":-1.356975,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":151398991},{"date":"2024-03-22","current":-1.423315,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":140611781},{"date":"2024-03-28","current":-1.401935,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":138499587},{"date":"2024-04-05","current":-1.432478,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":141517007},{"date":"2024-04-12","current":-1.423315,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":140611781},{"date":"2024-04-19","current":-1.313359,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":129749068},{"date":"2024-04-26","current":-1.1301,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":111644547},{"date":"2024-05-03","current":-1.136209,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":112248031},{"date":"2024-05-10","current":-1.21595,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":114661967},{"date":"2024-05-17","current":-1.116754,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":105307964},{"date":"2024-05-24","current":-0.995159,"twenty":-15.966078,"median":-5.288487,"eighty":-0.860941,"marketCap":93841768},{"date":"2024-05-31","current":-0.95996,"twenty":-15.966078,"median":-5.288487,"eighty":-0.860941,"marketCap":90522606},{"date":"2024-06-07","current":-0.943961,"twenty":-15.966078,"median":-5.282683,"eighty":-0.860941,"marketCap":89013895},{"date":"2024-06-14","current":-0.96316,"twenty":-15.966078,"median":-5.258417,"eighty":-0.860941,"marketCap":90824348},{"date":"2024-06-21","current":-0.96956,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":91427832},{"date":"2024-06-28","current":-0.95996,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":90522606},{"date":"2024-07-05","current":-0.96636,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":91126090},{"date":"2024-07-12","current":-1.299146,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":122507260},{"date":"2024-07-19","current":-1.331145,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":125524680},{"date":"2024-07-26","current":-1.257548,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":118584613},{"date":"2024-08-02","current":-1.151952,"twenty":-16.008223,"median":-5.232811,"eighty":-0.860549,"marketCap":108627127},{"date":"2024-08-09","current":-0.799884,"twenty":-16.008223,"median":-5.219754,"eighty":-0.854534,"marketCap":69400664},{"date":"2024-08-16","current":-0.869439,"twenty":-16.008223,"median":-5.204724,"eighty":-0.846337,"marketCap":75435505},{"date":"2024-08-23","current":-0.963338,"twenty":-16.008223,"median":-5.170108,"eighty":-0.846337,"marketCap":83582539},{"date":"2024-08-30","current":-0.973771,"twenty":-16.008223,"median":-5.149086,"eighty":-0.846337,"marketCap":84487765},{"date":"2024-09-06","current":-0.834661,"twenty":-16.008223,"median":-5.140911,"eighty":-0.842956,"marketCap":72418084},{"date":"2024-09-13","current":-1.074626,"twenty":-16.008223,"median":-5.104523,"eighty":-0.842956,"marketCap":93238284},{"date":"2024-09-20","current":-1.220692,"twenty":-16.008223,"median":-5.07622,"eighty":-0.842956,"marketCap":105911449},{"date":"2024-09-27","current":-1.172003,"twenty":-16.008223,"median":-5.056005,"eighty":-0.842956,"marketCap":101687060},{"date":"2024-10-04","current":-1.210259,"twenty":-16.008223,"median":-5.004447,"eighty":-0.842956,"marketCap":105006222},{"date":"2024-10-11","current":-1.151137,"twenty":-16.008223,"median":-4.962798,"eighty":-0.842956,"marketCap":99876608},{"date":"2024-10-18","current":-1.255469,"twenty":-16.008223,"median":-4.912471,"eighty":-0.842956,"marketCap":108928869},{"date":"2024-10-25","current":-1.258947,"twenty":-15.783249,"median":-4.85991,"eighty":-0.842956,"marketCap":109230611},{"date":"2024-11-01","current":-1.213736,"twenty":-15.402661,"median":-4.815435,"eighty":-0.842956,"marketCap":105307964},{"date":"2024-11-08","current":-1.144345,"twenty":-15.202709,"median":-4.785111,"eighty":-0.842956,"marketCap":98971382},{"date":"2024-11-15","current":-1.050146,"twenty":-14.670355,"median":-4.777025,"eighty":-0.842956,"marketCap":90824348},{"date":"2024-11-22","current":-0.97688,"twenty":-14.055521,"median":-4.73255,"eighty":-0.842956,"marketCap":84487765},{"date":"2024-11-29","current":-1.053635,"twenty":-13.770683,"median":-4.70325,"eighty":-0.842956,"marketCap":91126090},{"date":"2024-12-06","current":-0.159615,"twenty":-13.72108,"median":-4.649664,"eighty":-0.834899,"marketCap":13804697},{"date":"2024-12-13","current":-0.128041,"twenty":-13.506136,"median":-4.638411,"eighty":-0.827185,"marketCap":11073932},{"date":"2024-12-20","current":-0.126611,"twenty":-13.359584,"median":-4.586586,"eighty":-0.820859,"marketCap":10950217},{"date":"2024-12-27","current":-0.133623,"twenty":-13.288938,"median":-4.559388,"eighty":-0.809644,"marketCap":11556719},{"date":"2025-01-03","current":-0.164011,"twenty":-13.246851,"median":-4.534433,"eighty":-0.807718,"marketCap":14184892},{"date":"2025-01-10","current":-0.14388,"twenty":-13.18372,"median":-4.502605,"eighty":-0.799884,"marketCap":12443840},{"date":"2025-01-17","current":-0.130413,"twenty":-13.152155,"median":-4.426601,"eighty":-0.79584,"marketCap":11279116},{"date":"2025-01-24","current":-0.135786,"twenty":-13.119839,"median":-4.312651,"eighty":-0.79469,"marketCap":11743799},{"date":"2025-01-31","current":-0.121761,"twenty":-13.103304,"median":-4.191086,"eighty":-0.786174,"marketCap":10530796},{"date":"2025-02-07","current":-0.107841,"twenty":-12.950739,"median":-4.125642,"eighty":-0.776093,"marketCap":9326845},{"date":"2025-02-14","current":-0.116144,"twenty":-12.744814,"median":-4.0795,"eighty":-0.760749,"marketCap":10044991},{"date":"2025-02-21","current":-0.102921,"twenty":-12.680181,"median":-4.040776,"eighty":-0.74394,"marketCap":8901389},{"date":"2025-02-28","current":-0.09071,"twenty":-12.574212,"median":-3.996821,"eighty":-0.734417,"marketCap":7845292},{"date":"2025-03-07","current":-0.099956,"twenty":-12.358517,"median":-3.916236,"eighty":-0.728984,"marketCap":8644908},{"date":"2025-03-14","current":-0.102119,"twenty":-12.269833,"median":-3.868094,"eighty":-0.723384,"marketCap":8831988},{"date":"2025-03-21","current":-0.103375,"twenty":-11.885039,"median":-3.775996,"eighty":-0.718562,"marketCap":8940616},{"date":"2025-03-28","current":-0.123131,"twenty":-10.929494,"median":-3.547268,"eighty":-0.710316,"marketCap":9847954},{"date":"2025-04-04","current":-0.113047,"twenty":-10.655144,"median":-3.353412,"eighty":-0.698919,"marketCap":9041397},{"date":"2025-04-11","current":-0.122633,"twenty":-10.448396,"median":-3.001655,"eighty":-0.697715,"marketCap":9808124},{"date":"2025-04-17","current":-0.120268,"twenty":-10.281082,"median":-2.848446,"eighty":-0.693515,"marketCap":9618932},{"date":"2025-04-25","current":-0.267718,"twenty":-9.997718,"median":-2.646772,"eighty":-0.685082,"marketCap":21411915},{"date":"2025-05-02","current":-0.151517,"twenty":-9.811335,"median":-1.71308,"eighty":-0.677139,"marketCap":12118261},{"date":"2025-05-09","current":-0.174093,"twenty":-9.402585,"median":-1.607867,"eighty":-0.674441,"marketCap":13923885},{"date":"2025-05-16","current":-0.202103,"twenty":-9.002788,"median":-1.53233,"eighty":-0.670112,"marketCap":15301337},{"date":"2025-05-23","current":-0.269616,"twenty":-8.533644,"median":-1.494561,"eighty":-0.666194,"marketCap":20412847},{"date":"2025-05-30","current":-0.316394,"twenty":-8.208593,"median":-1.489165,"eighty":-0.664827,"marketCap":23954393},{"date":"2025-06-06","current":-0.359489,"twenty":-7.947417,"median":-1.470281,"eighty":-0.659728,"marketCap":27217130}],"updateTime":1749347278515}}}